Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of ADP receptor inhibitors given via nasogastric tube after cardiac arrest PCI
2013-005529-22Phase 4Completed
- Sponsor
- Rigshospitalet
- Start
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of prasugrel, ticagrelor and clopidogrel in myocardial infarction (MI), cardiac arrest (SCA) and coronary arteriosclerosis (3 arms), sponsored by Rigshospitalet. Primary endpoints: Platelet inhibition over time by multiple assays and Low responsiveness to ADP receptor inhibitors at 12 hours. Started Feb 2014; status: completed.
02
Drugs
prasugrelticagrelorclopidogrel
03
Conditions
myocardial infarction (MI)cardiac arrest (SCA)coronary arteriosclerosis
Beyond the preview
Go deeper on 2013-005529-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005529-22.